India's Sun Pharmaceutical has signed an agreement to acquire US biotech Concert Pharmaceuticals and its lead drug deuroxilitinib, in phase 3 testing for alopecia areata, a leading cause of hair loss.

Pfizer has picked up approval in the EU for Litfulo, its JAK inhibitor for severe alopecia areata, extending its challenge to Eli Lilly’s first-to-market Olumiant. The European ...

After that, I swore off hair removal creams in favour of using razors, electric shavers, at-home wax strips, and IPL devices; I couldn’t keep up with any of them. I finally decided to re-try ...